The AMDA is excited to announce a research grant opportunity for applicants who are involved in Pompe DiseaseA rare genetic disease in which the body cannot properly break down glycogen, leading to buildup that damages muscles and can affect breathing and, in some cases, the heart. research. This
December 13, 2022
Insurance 101 Webinar
Webinar Details Title: Insurance 101: Learning the Basics Date: Tuesday, December 13, 2022 Speaker:Amy DeStefanis, LCSW, CCM Webinar Overview:Insurance 101
November 1, 2022
An Open Letter to the Pompe Community
On October 28, Amicus Therapeutics issued a press release with an update on the progress of our Pompe program as
September 19, 2022
International Survey on Pompe Disease and Covid-19
Over the last 2 years the COVID-19 pandemic has had wide reaching effects on people all over the world. To
September 16, 2022
In Utero ERT Webinar
Webinar Details Title: In Utero EnzymeA protein that helps the body carry out chemical reactions. Replacement Therapy for Lysosomal Storage DiseasesA group of diseases in which substances build up inside lysosomes because the body cannot break them down properly. Date: Friday, September 16, 2022 Speaker:Jeniffer L. Cohen,
September 6, 2022
2021 Helen Walker Grant for Pompe Disease Winner Announcement
The AMDA is excited to announce that the 2021 Helen Walker Grant for Pompe Disease was awarded to Dr. Peter
August 26, 2022
Aquatic Physical Therapy Webinar
Webinar Details Title: Aquatic Exercise: Applications for Pompe Disease Date: Friday, August 26, 2022 Speaker:Dr. Kendra Lucas, PT, DPT, Aquatic
“On June 26, 2022, Astellas Pharma, Inc. (“Astellas”) issued a press release announcing that the U.S. Food and Drug Administration
The AMDA is excited to report that the final Voice of the Patient Report for the Pompe Patient-Focused Drug Development
Aro Biotherapeutics to Present New Preclinical Data Highlighting the Potential of Centyrin-siRNA Conjugates for the Treatment of Pompe Disease. To